Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank Value Type Network Comparison Type green description Interaction Map red network_comparison Filtered
Results: HTML CSV LaTeX
Showing element 6408 to 6457 of 16578 in total
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.897\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-beta (hnf-3b) (forkhead box protein a2). [source:swissprot;acc:q9y261]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.233\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.336\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1603\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
200.037\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
putative atp-dependent clp protease proteolytic subunit, mitochondrial precursor (ec 3.4.21.92) (endopeptidase clp). [source:swissprot;acc:q16740]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.216\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02089\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
heat shock factor binding protein 1. [source:swissprot;acc:o75506]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.62\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01595\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
148.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
septin-like protein kiaa0202 (fragment). [source:swissprot;acc:q92599]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
152.572\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.102\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
231.933\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
early endosome antigen 1, 162kd; early endosome-associated protein. [source:refseq;acc:nm\_003566]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.654\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.279\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1604\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
200.037\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
autophagy protein 5-like (apg5-like) (apoptosis-specific protein). [source:swissprot;acc:q9h1y0]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.216\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02089\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
211.614\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
protein kinase clk2 (ec 2.7.1.-) (cdc-like kinase 2). [source:swissprot;acc:p49760]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01593\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
200.288\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
inhibitor of nuclear factor kappa-b kinase epsilon subunit (ec 2.7.1.-) (i kappa-b kinase epsilon) (ikbke) (ikk-epsilon) (ikk-e) (inducible i kappa-b kinase) (ikk-i). [source:swissprot;acc:q14164]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.39\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.102\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
218.658\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
mitotic checkpoint protein bub3. [source:swissprot;acc:o43684]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
221.934\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.276\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1605\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
195.607\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
dual specificity protein phosphatase 15 (ec 3.1.3.48) (ec 3.1.3.16). [source:swissprot;acc:q9h1r2]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.691\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02088\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
213.916\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-alpha (hnf-3a) (forkhead box protein a1). [source:swissprot;acc:p55317]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.322\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01592\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.189\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
asparaginyl-trna synthetase, cytoplasmic (ec 6.1.1.22) (asparagine-- trna ligase) (asnrs). [source:swissprot;acc:o43776]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
201.291\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.102\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
218.658\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
zinc finger protein 207. [source:swissprot;acc:o43670]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
221.934\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.276\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1606\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
200.292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
dna polymerase epsilon p17 subunit (dna polymerase epsilon subunit 3) (chromatin accessibility complex 17) (huchrac17) (chrac-17). [source:swissprot;acc:q9nrf9]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.475\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02088\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.662\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
apolipoprotein a-i binding protein; apoa-i binding protein. [source:refseq;acc:nm\_144772]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
207.916\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0159\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.894\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
delta-interacting protein a (hepatitis delta antigen interacting protein a). [source:swissprot;acc:q15834]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
201.993\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.099\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
231.747\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
transcription factor-like protein mrgx (morf-related gene x protein) (mortality factor 4-like 2) (msl3-2 protein). [source:swissprot;acc:q15014]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.477\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.27\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1607\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
195.607\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
dual specificity protein phosphatase 5 (ec 3.1.3.48) (ec 3.1.3.16) (dual specificity protein phosphatase hvh3). [source:swissprot;acc:q16690]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.691\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02088\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
211.622\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
protein kinase clk3 (ec 2.7.1.-) (cdc-like kinase 3). [source:swissprot;acc:p49761]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
214.982\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01588\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.718\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
transketolase (ec 2.2.1.1) (tk). [source:swissprot;acc:p29401]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
201.817\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.099\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
231.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
transcription factor-like protein morf4 (mortality factor 4) (cellular senescence-related protein 1) (sen1). [source:swissprot;acc:q9y690]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.484\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.256\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1608\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
195.607\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
adenylosuccinate lyase (ec 4.3.2.2) (adenylosuccinase) (asl) (asase). [source:swissprot;acc:p30566]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.691\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02088\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.867\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 1 isoform b; dna-binding protein. [source:refseq;acc:nm\_003349]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.106\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01581\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.617\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ctf18, chromosome transmission fidelity factor 18 homolog; homolog of yeast chl12. [source:refseq;acc:nm\_022092]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.714\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.097\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
215.533\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
g1 to s phase transition protein 1 homolog (gtp-binding protein gst1-hs). [source:swissprot;acc:p15170]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
218.789\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.256\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1609\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
195.607\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
dual specificity protein phosphatase 13 (ec 3.1.3.48) (ec 3.1.3.16) (testis- and skeletal-muscle-specific dsp). [source:swissprot;acc:q9uii6]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.691\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02088\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.876\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
utp--glucose-1-phosphate uridylyltransferase 2 (ec 2.7.7.9) (udp- glucose pyrophosphorylase 2) (udpgp 2) (ugpase 2). [source:swissprot;acc:q16851]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.113\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0158\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
199.033\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
homeobox protein hox-c8 (hox-3a). [source:swissprot;acc:p31273]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.127\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.094\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.662\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
apolipoprotein a-i binding protein; apoa-i binding protein. [source:refseq;acc:nm\_144772]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
207.916\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.254\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1610\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.317\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
mus81 endonuclease. [source:refseq;acc:nm\_025128]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.31\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
204.886\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 2; 1 alpha,25-dihydroxyvitamin d3-inducible; enterocyte differentiation promoting factor; methyl methanesulfonate sensitive 2, s. cerevisiae, homolog of. [source:refseq;acc:nm\_003350]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.122\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01579\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
181.112\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
mawd binding protein (unknown protein 32 from 2d-page of liver tissue). [source:swissprot;acc:p30039]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
185.205\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.093\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
c18b11 homolog (44.9kd). [source:refseq;acc:nm\_152260]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.446\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.246\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1611\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.317\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
similar to hepatocellular carcinoma-associated antigen hca557b. [source:refseq;acc:nm\_145280]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.31\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
217.877\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
p10-binding protein. [source:refseq;acc:nm\_024491]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
221.313\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01577\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
193.656\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hyaluronan synthase 2 (ec 2.4.1.212) (hyaluronate synthase 2) (hyaluronic acid synthase 2) (ha synthase 2). [source:swissprot;acc:q92819]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.747\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.091\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
z-protein (protein cgi-119) (s1r protein). [source:swissprot;acc:q9hc24]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.446\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.246\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1612\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.317\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hepatocellularcarcinoma-associated antigen hca557a. [source:refseq;acc:nm\_015433]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.31\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
224.902\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
enthoprotin; epsin 4; clathrin interacting protein localized in the trans-golgi region. [source:refseq;acc:nm\_014666]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
221.426\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0157\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
193.661\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hyaluronan synthase 1 (ec 2.4.1.212) (hyaluronate synthase 1) (hyaluronic acid synthase 1) (ha synthase 1) (huhas1). [source:swissprot;acc:q92839]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.752\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.091\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
pp1201 protein. [source:refseq;acc:nm\_022152]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.446\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.246\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1613\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
185.241\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hiv-1 tat interactive protein 2, 30kda; tat-interacting protein (30kd); hiv-1 tat interactive protein 2, 30 kda; hiv-1 tat interactive protein 2, 30 kd. [source:refseq;acc:nm\_006410]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
182.378\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0157\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
188.847\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
mitochondrial gtp binding protein isoform v. [source:refseq;acc:nm\_032620]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
192.787\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02086\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
193.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hyaluronan synthase 3 (ec 2.4.1.212) (hyaluronate synthase 3) (hyaluronic acid synthase 3) (ha synthase 3). [source:swissprot;acc:o00219]\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
197.74\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.09\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
lifeguard; kiaa0950 protein. [source:refseq;acc:nm\_012306]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.446\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.246\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1614\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ras-related protein rap-2b. [source:swissprot;acc:p17964]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
202.026\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02085\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
213.897\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-beta (hnf-3b) (forkhead box protein a2). [source:swissprot;acc:q9y261]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.233\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0156\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.406\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
zinc finger-like protein 9. [source:refseq;acc:nm\_033414]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
202.494\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.088\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
214.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
sterol regulatory element binding protein-2 (srebp-2) (sterol regulatory element-binding transcription factor 2). [source:swissprot;acc:q12772]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.446\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.246\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
200.988\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
cpg binding protein (protein containing phd finger and cxxc domain 1). [source:swissprot;acc:q9p0u4]\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.179\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02085\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/